Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2015 | 1 |
2017 | 1 |
2024 | 0 |
Search Results
2 results
Results by year
Filters applied: . Clear all
Page 1
Recombinant factor XIII prophylaxis is safe and effective in young children with congenital factor XIII-A deficiency: international phase 3b trial results.
J Thromb Haemost. 2017 Aug;15(8):1601-1606. doi: 10.1111/jth.13748. Epub 2017 Jul 10.
J Thromb Haemost. 2017.
PMID: 28581691
Free article.
Clinical Trial.
Neoplasm-induced bleeding in inherited, heterozygous FXIII-A deficiency.
Ivaškevičius V, Goldmann G, Biswas A, Westhofen P, Thomas A, Marquardt N, Horneff S, Klein C, Rühl H, Pötzsch B, Oldenburg J.
Ivaškevičius V, et al.
Hamostaseologie. 2015;35 Suppl 1:S32-5.
Hamostaseologie. 2015.
PMID: 26540128
Item in Clipboard
Cite
Cite